Detalles de la búsqueda
1.
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Curr Oncol
; 30(6): 5456-5469, 2023 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366896
2.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Cancers (Basel)
; 15(24)2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136304
3.
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Anticancer Res
; 41(5): 2553-2561, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952483
Resultados
1 -
3
de 3
1
Próxima >
>>